Insider · CIK 0001803424

Markels John

Reports to the SEC for 3 companies · SAN CARLOS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001803424

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-16	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23K sh	—	—	23,029
2026-06-05	ARCTArcturus Therapeutics Holdings Inc. · Stock option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2025-06-12	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director	AAward	+25K sh	—	—	96,384
2025-06-12	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2025-06-09	ARCTArcturus Therapeutics Holdings Inc. · Stock option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-06-14	ARCTArcturus Therapeutics Holdings Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,131 sh	—	—	3,131
2024-06-14	ARCTArcturus Therapeutics Holdings Inc. · Deferred Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,131 sh	—	—	0
2024-06-14	ARCTArcturus Therapeutics Holdings Inc. · Stock option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-06-04	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director	AAward	+25K sh	—	—	71,384
2024-06-04	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2023-08-01	ARCTArcturus Therapeutics Holdings Inc. · Stock option (right to buy)A Award	Director	AAward	+11.9K sh	—	—	11,869
2023-08-01	ARCTArcturus Therapeutics Holdings Inc. · Deferred Stock UnitsA Award	Director	AAward	+3,131 sh	—	—	3,131
2023-06-01	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director	AAward	+13.9K sh	—	—	46,384
2023-06-01	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+27.8K sh	—	—	27,750
2022-12-08	ARCTArcturus Therapeutics Holdings Inc. · Stock option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-12-08	ARCTArcturus Therapeutics Holdings Inc. · Stock option (right to buy)A Award	Director	AAward	+6,986 sh	—	—	6,986
2022-06-03	SGMOQSANGAMO THERAPEUTICS, INCP Purchase	Director	PPurchase	+6,784 sh	$3.69	+$25K	32,484
2022-02-25	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director	AAward	+12.5K sh	—	—	25,700
2022-02-25	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2021-02-25	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director	AAward	+8,200 sh	—	—	13,200
2021-02-25	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+16.4K sh	—	—	16,400
2020-02-11	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director	AAward	+5,000 sh	—	—	5,000
2020-02-11	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Jul 164
Markels John0001803424-26-000004
SEC(opens sec.gov)
Jun 154
Markels John0001193805-26-000826
SEC(opens sec.gov)
Jun 164
Markels John0001415889-25-017371
SEC(opens sec.gov)
Jun 114
Markels John0001193805-25-000875
SEC(opens sec.gov)
Jun 184
Markels John0001193805-24-000827
SEC(opens sec.gov)
Jun 64
Markels John0001415889-24-015757
SEC(opens sec.gov)
Aug 34
Markels John0001193805-23-001074
SEC(opens sec.gov)
Jun 54
Markels John0001209191-23-034396
SEC(opens sec.gov)
Dec 134
Markels John0001193805-22-001718
SEC(opens sec.gov)
Jun 64
Markels John0001209191-22-034538
SEC(opens sec.gov)
Mar 14
Markels John0001209191-22-014139
SEC(opens sec.gov)
Mar 14
Markels John0001209191-21-015500
SEC(opens sec.gov)

Companies

Address

C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, SUITE 300

SAN CARLOS, CA, 94070